See also this year's filing and all EDGAR filings for this company.
PDF Report 0001479290_2016_Revance_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001479290, Revance Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 253,963,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 19,708,000 |
| 3 | remainder_Assets | 2,151,000 |
| 4 | LiabilitiesCurrent | 12,037,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 10,533,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 25,088,000 |
| 9 | ResearchAndDevelopmentExpense | 47,529,000 |
| 10 | remainder_Expenses | 1,190,000 |
| 11 | remainder_Revenues | 300,000 |
| 12 | remainder_NetIncome | 31,000 |
| 13 | remainder_ComprehensiveNetIncome | -40,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 275,822,000 |
| 1 | Liabilities | 22,570,000 |
| 2 | Expenses | 73,807,000 |
| 3 | Revenues | 300,000 |
| 4 | StockholdersEquity | 253,252,000 |
| 5 | NetIncome | -73,476,000 |
| 6 | ComprehensiveNetIncome | -73,496,000 |
| 7 | BaseVar | 186,285,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.21 |
| 9 | EconomicCapitalRatio | 3.83 |
Edgar->Model Mapping
Feature Distribution
Change over Time
